ACHP submitted comments to CMS on the CY 2027 Medicare Advantage Advance Notice, urging reforms to risk adjustment, the effective growth rate, USPCC calculations and Star Ratings to support regional health plans and seniors.
ACHP released a statement in response to the voluntary BALANCE Model for GLP-1s from CMS.
ACHP member plans are leading the way with evidence-based prescribing, lifestyle integration and smart coverage that ensures the right patients get the right treatment at the right time.
ACHP President and CEO Ceci Connolly released a statement in response to CMS’ final CY2026 Medicare Advantage and Part D rule.
As the only national payer group to push for comprehensive drug reforms, ACHP believes that it is past time for pharmaceutical companies to answer for their pricing practices.
